More Combinations like Nivolumab and Ipilimumab Coming for Lung, Bladder, and Kidney Cancer
Lawrence Fong, MD of University of California, San Francisco discusses the use of more combinations therapies, like Nivolumab and Ipilimumab. This combination therapy is FDA approved for Melanoma, but...
Author: ASCO-SITC2017
Added: 03/06/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Bladder Cancer | Cancer | Cancer & Oncology | Kidney Cancer | Legislation | Melanoma | Skin Cancer | Urology & Nephrology | Yervoy